Ukraine’s Wartime Healthcare: Inna Ivanenko on Access, PMG, and Medicines

Why It Matters

Ensuring continuous, affordable medical access stabilizes public health, supports civilian resilience, and curbs brain‑drain amid ongoing conflict.

Key Takeaways

• 2,530 Ukrainian medical facilities damaged; 327 destroyed since invasion
• Mobile clinics and pharmacies keep care reachable in frontline zones
• Mid‑year budget boost added ~3 bn hryvnia (~$77 m) for essential drugs
• Three oncology drugs moved to outpatient Affordable Medicines program
• Unreliable suppliers cause up to nine‑month delays for life‑saving medicines

Pulse Analysis

Ukraine’s health sector faces an unprecedented test of resilience as more than 2,500 facilities have been hit since the full‑scale invasion, with 327 completely destroyed. Despite the devastation, rehabilitation efforts—backed by NGOs like Patients of Ukraine and partners such as Crown Agents—have restored 700 hospitals and deployed mobile clinics and pharmacies to reach patients in contested zones. These mobile units act as lifelines, delivering diagnostics, medicines, and even heating, allowing civilians to receive care without risking dangerous travel routes.

Financially, the Ukrainian government announced a mid‑year infusion of roughly 3 bn hryvnia (about $77 million) to fund essential drugs, a modest but critical step that enabled three innovative oncology treatments to transition from hospital‑only delivery to the Affordable Medicines program. This shift lets patients collect therapy at local pharmacies, reducing travel burdens and out‑of‑pocket costs. Yet systemic bottlenecks remain: unreliable suppliers, lengthy registration processes, and contracts awarded to firms lacking local approvals have produced delays of up to nine months for life‑saving medications, especially second‑ and third‑line cancer therapies.

The broader implications extend beyond health outcomes. Persistent drug shortages and uneven service coverage drive families with chronic or rare‑disease patients to seek treatment abroad, risking a loss of human capital essential for Ukraine’s reconstruction. Strengthening primary care, optimizing the legacy Soviet‑era hospital network, and instituting stricter supplier vetting could improve efficiency and retain talent. Continued donor support and strategic investment in procurement infrastructure are vital to safeguard equitable access for IDPs, older adults, and remote communities, ensuring the health system remains a pillar of national resilience.